Icon

LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE (nda022344)- (300MG;300MG)

LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE AUROBINDO PHARMA LTD
300MG;300MG
No Yes
Expired Expired
None None
None No
Lamivudine and tenofovir disoproxil fumarate tablets is a two-drug combination of lamivudine (3TC) and tenofovir disoproxil fumarate (TDF), both nucleo(t)side reverse transcriptase inhibitors and is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg.
0 0 0
Total Other Developers 9
Drugs with Suitability No
300MG;300MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.